Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: REHOVOT, Israel, Aug. 19, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company aiming to revolutionize the development of life-science- based products, today announced its financial results for the second quarter ended June 30, 2025. Mr. Ofer Haviv, Evogene's President and CEO stated: "Evogene is entering a transformative phase, centered on the strategic repos ...